期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | ATHEROSCLEROSIS LetPub Score 7.7
50 ratings
Rate
Reputation 8.8 Influence 6.6 Speed 9.1 | ||||||||||||||||
期刊簡稱 | ATHEROSCLEROSIS | ||||||||||||||||
ISSN | 0021-9150 | ||||||||||||||||
E-ISSN | 1879-1484 | ||||||||||||||||
h-index | 159 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 4.10%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://www.journals.elsevier.com/atherosclerosis/ | ||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/ATH | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Elsevier Ireland Ltd | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||
創刊年 | 1970 | ||||||||||||||||
每年文章數 | 193每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 34.14% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0021-9150%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 3 Month(s) 來自Elsevier的數據: Average 7.7 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: About 33.33% 來自Elsevier的數據: 32% | ||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 4.7 Week(s) | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 下一頁 末頁 (頁 | |
[ATHEROSCLEROSIS] 的評論 | 撰寫評論 |
作者: 震雷宛畅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-07 16:09:51 評論於 Do we need to laminate this magazine?(0) 讚! | 震雷宛畅 |
作者: 含莲酱吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-18 09:06:19 評論於 Review Speed: 6.0 | Submission Acceptance Rate: 50.0 Experience Sharing: 1(0) 讚! | 含莲酱吖 |
作者: 伯吉斯尤利西斯 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-31 20:11:32 評論於 It has been a week since the revised manuscript was sent back. Is there still hope for a decision in process?(0) 讚! | 伯吉斯尤利西斯 |
作者: 惜芹可爱吗 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-21 19:06:22 評論於 You(0) 讚! | 惜芹可爱吗 |
作者: 惜芹可爱吗 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-21 17:03:03 評論於 Is this magazine open to having co-corresponding authors (two correspondents)?(0) 讚! | 惜芹可爱吗 |
作者: 努力啊大巧莲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-01 09:42:04 評論於 Normally, it takes a long time to receive feedback even when returning to editing. Last year, I waited a month at the "decision in process" step when I submitted(0) 讚! | 努力啊大巧莲 |
作者: 风啸诗霜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-15 20:21:14 評論於 All review completed for nearly a month now, is this normal? The reviewers have all finished their evaluations, but I still haven't received any feedback. I'm getting anxious(0) 讚! | 风啸诗霜 |
作者: 碧桃含文 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-16 16:56:44 評論於 Received at Editorial Office: 5 May 2022 Article revised: 12 Nov 2022 Article accepted for publication: 13 Dec 2022(0) 讚! | 碧桃含文 |
作者: 碧桃含文 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-16 13:52:02 評論於 Review Speed: 1.0 Experience Sharing: Received at Editorial Office 5 May 2022 Article revised 12 Nov 2022 Article accepted for publication 13 Dec 2022(0) 讚! | 碧桃含文 |
作者: 碧桃含文 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-11 18:46:41 評論於 Western holidays are coming(0) 讚! | 碧桃含文 |
作者: 珉林恨桃 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-13 15:52:34 評論於 Research focus: Atherosclerosis; Cardiovascular; Clinical epidemiology Experience sharing: Been under review for almost two months and only received one acceptance invitation... Is everyone else this slow too?(0) 讚! | 珉林恨桃 |
作者: 碧桃含文 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-04 17:01:38 評論於 That means it has not been submitted for external review yet(0) 讚! | 碧桃含文 |
作者: 努力啊大巧莲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-27 17:32:28 評論於 There is a link in the corresponding author's email(0) 讚! | 努力啊大巧莲 |
作者: 珉林恨桃 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-26 10:00:27 評論於 I didn't see the tracking link after being under re(0) 讚! | 珉林恨桃 |
作者: 努力啊大巧莲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-23 16:06:22 評論於 Decision in process. Rejection after one month. A very long rejection letter, I can see that the reviewers are definitely industry experts, and their comments are very insightful. Will submit to another journal(0) 讚! | 努力啊大巧莲 |
作者: 碧桃含文 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-11 14:58:25 評論於 Around 6:20(0) 讚! | 碧桃含文 |
作者: 努力啊大巧莲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-09 20:22:52 評論於 What day did you make this decision? Was it also in July?(0) 讚! | 努力啊大巧莲 |
作者: 碧桃含文 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-08 15:26:50 評論於 There was no rush, so I made my decision in a week(0) 讚! | 碧桃含文 |
作者: 努力啊大巧莲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-03 22:40:59 評論於 OP, have you sent any emails to urge progress midway? I have been in the decision process for 2 weeks, not sure if it's appropriate to ask. Seeking advice(0) 讚! | 努力啊大巧莲 |
作者: 碧桃含文 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-31 20:50:03 評論於 Please translate the following paragraph into English and Japanese, with titles ":" and ":"(0) 讚! | 碧桃含文 |
作者: 碧桃含文 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-27 20:15:59 評論於 Let's cheer each other on(0) 讚! | 碧桃含文 |
作者: 努力啊大巧莲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-27 10:30:54 評論於 Decision in process for a whole week now, the review process seems to be slowing down recently, as Europe is on summer holiday and the editors are mostly university professors. Feeling restless(0) 讚! | 努力啊大巧莲 |
作者: 碧桃含文 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-27 08:47:58 評論於 What did the original poster say? What was the final result?(0) 讚! | 碧桃含文 |
作者: 努力啊大巧莲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-19 13:44:28 評論於 OP is excellent. Keep it up(0) 讚! | 努力啊大巧莲 |
作者: 努力啊大巧莲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-12 18:14:41 評論於 Review speed: 1.0 | Submission acceptance rate: 25.0 Experience sharing: The experiment design is relatively simple, and the supervisor requested that it must be submitted to AS. I also know that the likelihood of rejection is high. I will first provide some data on the submission time. Submitted to Editor assigned took about 3 days, with the editor status lasting about 4 days. After updating the date once midway, it quickly entered the "Under review" stage. I saw 2+ reviewer invitations sent out in the Tracking link, with initially only 1 agreeing to review. Initially thinking it was only 1 reviewer, I was happy, but in the end, it was 2+. It has been exactly 1 month since submission, with all reviews completed, and now in the "Decision in process" stage. I am preparing for the next journal. I hope the supervisor can achieve his dream through his next student(0) 讚! | 努力啊大巧莲 |
首頁 上一頁 1 2 3 下一頁 末頁 (頁 |
Contact us